Search results
Results From The WOW.Com Content Network
The Federal Trade Commission had its first win earlier this week in its crusade to block drug company deals: Sanofi on Monday ended its up-to-$735 million licensing deal with Maze Therapeutics.
AstraZeneca claimed the deal undervalued the company. [15] 4 2014 Pfizer: Astra Zeneca: 99 127 AstraZeneca claimed the deal undervalued the company. [16] 5 1999 Pfizer: Warner–Lambert: 82.4 151 Pfizer made a hostile bid, just after the announcement of a $72 billion deal with Wyeth, the eventual purchase price would be in excess of $90 billion ...
This list is based on the Forbes Global 2000, which ranks the world's 2,000 largest publicly traded companies.The Forbes list takes into account a multitude of factors, including the revenue, net profit, total assets and market value of each company; each factor is given a weighted rank in terms of importance when considering the overall ranking.
The Cathay Drug Company operates exclusively in the Philippines. Its main area of specialization is the marketing and distribution of pharmaceutical drugs and products for both humans and animals. The company acquires its products through licensing agreements with domestic and international firms. Among its main suppliers are the following:
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
The Liusons, a traditional Chinese family has been involved in the pharmaceutical industry since 1959 through Pacific Pharma, an importer and wholesaler of drugs. [3] In 1983, Pacific Pharma shifted to investing on generic drugs. [3] The company initially largely sold generic drugs wholesale to government hospitals. [4]
In the first big-ticket biopharma M&A of the year, Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) announced a deal to buy cannabinoid drug company GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH). The Jazz-GW ...